2m 2m 2m 2m 2m 2m 2m
LONGEVERON-A (LGVN)
NASDAQ
$0.78+$0.02 (+2.63%)
Price as of Jun 03, 2026 6:43 PM EDT- $23.3MMarket Cap
- -35.59%1-Year Change
- BiotechnologyIndustry
LONGEVERON-A (LGVN)
$0.78+$0.02 (+2.63%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 954,000 -60.12% | 2.4M +237.38% | 709,000 -41.98% | 1.2M -6.43% | |
Cost of Revenue | 396,000 -22.05% | 508,000 +4.10% | 488,000 -32.69% | 725,000 +1.26% | |
Gross Profit | 803,000 -57.38% | 1.9M +752.49% | 221,000 -55.53% | 497,000 -15.76% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | 783,000 -25.50% | 1.1M +377.73% | |
Research and Development Expense | -12.0M +47.98% | -8.1M -10.25% | -9.1M -3.24% | -9.4M +32.12% | |
Depreciation and Amortization Expense | 1.2M +27.97% | 958,000 +1.27% | 946,000 +5.94% | 893,000 +346.50% | |
Total Operating Expenses | 24.1M +30.88% | 18.4M -13.38% | 21.3M +14.62% | 18.5M +2.74% | |
Operating Profit | -23.3M +40.95% | -16.5M -21.43% | -21.0M +16.55% | -18.0M +3.36% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -1.4M +34,850.00% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -1.4M +34,850.00% | |
Total Nonoperating Income and Expense | 583,000 +6.19% | 549,000 +242.97% | -384,000 -51.52% | -792,000 -292.70% | |
Income before Taxes | -22.7M -7.79% | -24.6M +10.86% | -22.2M +17.92% | -18.8M +10.50% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -22.7M +42.14% | -16.0M -25.41% | -21.4M +13.69% | -18.8M +10.50% | |
Net Income from Continuing Operations Applicable to Common | -22.7M -7.79% | -24.6M +10.86% | -22.2M +17.92% | -18.8M +10.50% | |
Basic EPS and Net Income | -1.29 -50.76% | -2.62 +156.86% | -1.02 +13.33% | -0.90 0.00% | |
Diluted EPS and Net Income | -1.29 -50.76% | -2.62 +156.86% | -1.02 +13.33% | -0.90 0.00% | |
Basic Weighted Average Shares | 17.6B +86.76% | 9.4B +43,199.78% | 21.7M +3.65% | 21.0M +10.86% | |
Diluted Weighted Average Shares | 17.6B +86.76% | 9.4B +43,199.78% | 21.7M +3.65% | 21.0M +10.86% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.7M -75.76% | 19.2M +288.60% | 4.9M -52.88% | 10.5M -59.07% | |
Short-Term Investments | N/A N/A | 0 -100.00% | 412,000 N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 4.7M -75.76% | 19.2M +258.74% | 5.4M -48.96% | 10.5M -70.10% | |
Total Current Assets | 5.5M -72.22% | 19.6M +235.57% | 5.8M -71.16% | 20.3M -42.68% | |
Accumulated Depreciation | 5.8M +12.54% | 5.2M +16.53% | 4.4M +19.13% | 3.7M +22.36% | |
Property and Plant and Equipment and Net | 1.8M -25.03% | 2.4M -3.16% | 2.5M -14.24% | 2.9M -3.69% | |
Total Long-Term Assets | 176,000 -12.87% | 202,000 +4.66% | 193,000 -20.90% | 244,000 +37.85% | |
Total Assets | 10.3M -59.85% | 25.6M +111.61% | 12.1M -55.94% | 27.4M -35.90% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 64.8M +123,394.78% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 4.4M +67.22% | |
Total Current Liabilities | 4.1M +58.29% | 2.6M -33.61% | 3.9M -20.13% | 4.9M +79.80% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | 2.0M -21.65% | |
Total Long-Term Liabilities | 499,000 -54.18% | 1.1M -24.79% | 1.4M N/A | N/A N/A | |
Total Liabilities | 4.6M +24.93% | 3.7M -31.22% | 5.3M -22.76% | 6.9M +30.06% | |
Retained Earnings | -132.3M +20.71% | -109.6M +28.97% | -85.0M +35.38% | -62.8M +42.87% | |
Total Stockholders Equity | 5.7M -74.07% | 21.9M +224.68% | 6.7M -67.12% | 20.5M -45.26% | |
Total Shares Outstanding | 21.4M +44.01% | 14.9M -40.69% | 25.1M +19.45% | 21.0M +306.12% | |
Cash Flow | |||||
Cash from Operating Activities | -18.6M +34.45% | -13.9M -27.02% | -19.0M +36.03% | -14.0M +44.97% | |
Capital Expenditures | 245,000 -62.60% | 655,000 +117.61% | 301,000 -47.10% | 569,000 +72.42% | |
Cash from Investing Activities | -595,000 -7.03% | -640,000 -107.82% | 8.2M +1,309.16% | -677,000 -93.67% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 4.7M -83.78% | 28.8M +447.15% | 5.3M +1,133.79% | -509,000 -101.13% | |
Financials Ratio | |||||
Gross Margin | 58.49% -25.74% | 78.76% +152.68% | 31.17% -23.36% | 40.67% N/A | |
Operating Margin | -2,440.99% +253.40% | -690.72% -76.71% | -2,966.01% +100.88% | -1,476.51% N/A | |
Return on Assets | -126.77% +49.35% | -84.88% -21.73% | -108.44% +102.03% | -53.68% N/A | |
Return on Equity | -164.75% +47.64% | -111.59% -29.01% | -157.19% +141.85% | -65.00% N/A | |
Revenue Growth | -60.12% -125.33% | 237.38% +665.45% | -41.98% +552.69% | -6.43% N/A | |
Current Ratio | 1.33 -82.45% | 7.60 +405.44% | 1.50 -63.90% | 4.17 N/A | |
Cash Ratio | 1.14 -84.69% | 7.45 +485.30% | 1.27 -41.00% | 2.16 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | 0.31 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | 0.23 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow